Glenmark arm gets Russian health ministry nod for nasal spray Ryaltris

This new innovative addition to our portfolio is yet another major step in strengthening Glenmarks respiratory focus in Russia and the CIS region, Kantor added.Shares of Glenmark Pharma were trading 0.18 per cent higher at Rs 483.25 apiece on BSE.

PTI | New Delhi | Updated: 22-02-2021 10:43 IST | Created: 22-02-2021 10:16 IST
Glenmark arm gets Russian health ministry nod for nasal spray Ryaltris
Glenmark Pharmaceuticals Limited Image Credit: ANI

Glenmark Pharma on Monday its Swiss subsidiary has received marketing approval from the Russian health regulator for its nasal spray Ryaltris. Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children over 12 years of age. The drug relieves symptoms of allergic rhinitis, including stuffy nose, runny nose, nasal itching, sneezing, as well as itchy, red and watery eyes. ''Glenmark Specialty received marketing approval from the Ministry of Health of the Russian Federation for its innovative Ryaltris Nasal Spray - a novel fixed-dose combination nasal spray. This paves the way for commercialization of Ryaltris in Russia which is expected to be made available to patients in the country in Q1 FY 2021-22,'' Glenmark Pharmaceuticals said in a regulatory filing. In Russia, allergic rhinitis affects 10-20 per cent of the population on average, with certain regions having a higher prevalence rate of 18-38 per cent. Allergic rhinitis can impact a person's quality of life and lead to functional impairments, as well as increase the risk of having asthma, the company said.

Csaba Kantor Senior Vice President – Russia and CIS region, Glenmark Pharmaceuticals, said Russia is one of the key markets for the company and it consistently looking to expand its product portfolio.

"Glenmark has built strong capabilities in the area of respiratory medicine and is among the leading players in this therapy area across several markets globally... This new innovative addition to our portfolio is yet another major step in strengthening Glenmark's respiratory focus in Russia and the CIS region,'' Kantor added.

Shares of Glenmark Pharma were trading 0.18 per cent higher at Rs 483.25 apiece on BSE.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

East African women traders: 'Celebrating the past, planning for the future'

COVID-19 has hit women disproportionately hard across East Africa, especially those working in the informal sector. Lessons must be learnt to prevent this from happening again....

Viral variants and vaccine nationalism pose two-pronged threat to Covid victory

... ...

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

Videos

Latest News

Jaishankar, EU's Margrethe Vestager discuss preparation of virtual India-EU summit

External Affairs Minister S Jaishankar had a discussion with Margrethe Vestager, the Executive Vice President of the European Commission, on Friday on the preparations for the virtual India-EU Summit. A warm and productive meeting with EVP ...

Israeli police say dozens arrested in Jerusalem clashes

Israeli police say 44 people were arrested and 20 officers were wounded in a night of chaos in Jerusalem, where security forces separately clashed with Palestinians angry about Ramadan restrictions and Jewish extremists who held an anti-Ara...

Lifting lockdown brings surge of activity for UK companies - PMI

A deluge of new orders swept through British businesses in April as the country lifted some of its COVID-19 restrictions, according to a survey on Friday that pointed to a rapid rebound for the pandemic-hit UK economy. The preliminary flash...

Serbia, Kosovo must work harder to normalise relations, Germany says

Germany urged Serbia and Kosovo to make more efforts to reach progress in talks about normalization of their relationship, more than 20 years after Belgrade lost control of its former southern province in 1999.It is the right time to contin...

Give Feedback